Activated kinases in ALL: time to act
- PMID: 28642359
- DOI: 10.1182/blood-2017-05-780015
Activated kinases in ALL: time to act
Conflict of interest statement
Conflict-of-interest disclosure: The author declares no competing financial interests.
Comment on
-
Targetable kinase gene fusions in high-risk B-ALL: a study from the Children's Oncology Group.Blood. 2017 Jun 22;129(25):3352-3361. doi: 10.1182/blood-2016-12-758979. Epub 2017 Apr 13. Blood. 2017. PMID: 28408464 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources

